Encompass Health Co. (NYSE:EHC) Shares Sold by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC cut its stake in shares of Encompass Health Co. (NYSE:EHC) by 3.1% in the fourth quarter, Holdings Channel.com reports. The fund owned 62,685 shares of the company’s stock after selling 2,025 shares during the period. Mutual of America Capital Management LLC’s holdings in Encompass Health were worth $5,789,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in EHC. Point72 Asset Management L.P. increased its position in shares of Encompass Health by 2,458.5% during the third quarter. Point72 Asset Management L.P. now owns 869,104 shares of the company’s stock valued at $83,990,000 after acquiring an additional 835,135 shares during the last quarter. Jennison Associates LLC acquired a new stake in shares of Encompass Health during the fourth quarter valued at about $52,094,000. abrdn plc acquired a new stake in shares of Encompass Health during the fourth quarter valued at about $17,846,000. Thrivent Financial for Lutherans increased its position in shares of Encompass Health by 26.0% during the third quarter. Thrivent Financial for Lutherans now owns 760,496 shares of the company’s stock valued at $73,494,000 after acquiring an additional 156,938 shares during the last quarter. Finally, Franklin Resources Inc. increased its position in shares of Encompass Health by 22.0% during the third quarter. Franklin Resources Inc. now owns 700,021 shares of the company’s stock valued at $67,412,000 after acquiring an additional 126,000 shares during the last quarter. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Encompass Health Stock Down 0.4 %

Shares of Encompass Health stock opened at $99.73 on Tuesday. Encompass Health Co. has a 52-week low of $74.27 and a 52-week high of $104.55. The company has a 50 day moving average of $96.53 and a 200 day moving average of $96.50. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84. The company has a market capitalization of $10.05 billion, a P/E ratio of 22.36, a P/E/G ratio of 2.31 and a beta of 0.90.

Encompass Health (NYSE:EHC) last issued its quarterly earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. As a group, research analysts forecast that Encompass Health Co. will post 4.8 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, April 17th. Shareholders of record on Tuesday, April 1st will be issued a dividend of $0.17 per share. The ex-dividend date is Tuesday, April 1st. This represents a $0.68 dividend on an annualized basis and a yield of 0.68%. Encompass Health’s payout ratio is currently 15.25%.

Insiders Place Their Bets

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of the firm’s stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total transaction of $495,578.18. Following the sale, the chief accounting officer now owns 69,164 shares of the company’s stock, valued at approximately $6,798,129.56. This trade represents a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 2.10% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several research analysts have recently commented on the stock. KeyCorp raised their price objective on shares of Encompass Health from $117.00 to $120.00 and gave the company an “overweight” rating in a research note on Monday, February 10th. Barclays raised their price objective on shares of Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday, February 7th. William Blair reissued an “outperform” rating on shares of Encompass Health in a research note on Friday, February 7th. StockNews.com raised shares of Encompass Health from a “hold” rating to a “buy” rating in a research note on Saturday, February 15th. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $110.00 price objective on shares of Encompass Health in a research note on Tuesday, February 11th. Ten analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, Encompass Health has an average rating of “Buy” and an average price target of $107.67.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.